+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120860
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The colorectal cancer molecular diagnostics market is evolving rapidly, enabling healthcare leaders to improve diagnostic precision, patient outcomes, and operational efficiency as molecular technologies and clinical applications develop.

Market Snapshot: Colorectal Cancer Molecular Diagnostics Market Size and Growth

The colorectal cancer molecular diagnostics market grew from USD 3.11 billion in 2025 to USD 3.31 billion in 2026. It is expected to continue growing at a CAGR of 6.82%, reaching USD 4.94 billion by 2032.

Scope & Segmentation

This analysis provides comprehensive coverage of the global colorectal cancer molecular diagnostics landscape, detailing current and emerging technologies, market segments, and regions addressed:

  • Technologies: Coverage spans next-generation sequencing (NGS), digital PCR, quantitative PCR, fluorescence in situ hybridization (FISH), and microarray methods for genomic profiling and biomarker assessment.
  • Product Types: Includes instruments such as sequencers and PCR systems, consumables covering kits and reagents, alongside bioinformatics and data analysis software.
  • Clinical Applications: Encompasses companion diagnostics, minimal residual disease (MRD) monitoring, predictive and prognostic testing to support individualized treatment decisions.
  • Biomarkers: Analysis of KRAS, BRAF, and NRAS mutations, and microsatellite instability status—all critical to therapy alignment and eligibility for clinical trials.
  • Sample Types: Covers tissue biopsies, blood-derived specimens (plasma, serum), and stool-based assays, reflecting evolving specimen workflows and diagnostic sensitivity requirements.
  • End Users: Academic and research institutes, clinical and reference laboratories, hospitals, and diagnostic centers, each with distinct workflow and reporting priorities.
  • Regions: In-depth perspective on the Americas, Europe, Middle East, Africa, and Asia-Pacific, with attention to infrastructure development and regulatory requirements.

Key Takeaways: Strategic Insights for Decision-Makers

  • Molecular diagnostics in colorectal cancer is shifting towards integrated molecular profiles and informatics-driven clinical decision support to optimize patient-specific care.
  • Alignment between laboratory platforms, clinical workflows, and reimbursement policies is essential, especially given differences in regional regulatory environments and healthcare infrastructure maturity.
  • The convergence of higher-throughput sequencing, more sensitive PCR, and standardized bioinformatics tools is reducing variability, improving test accuracy, and enabling earlier detection and monitoring of colorectal cancer.
  • Clinical guidelines and payer expectations are prompting stakeholders to demonstrate real-world clinical utility and cost-effectiveness to drive broader adoption and maintain patient access to innovative testing.
  • Partnerships between clinical, commercial, and academic sectors are critical for validating novel biomarkers and scaling successful diagnostic solutions for diverse markets.

Assessing Tariff Impact: Operational and Strategic Implications

Recent tariff adjustments in the United States have had measurable effects on procurement and supply chain strategies in the colorectal cancer molecular diagnostics market. Increased import costs for instruments and reagents have prompted laboratories and manufacturers to reconsider supplier portfolios, localize supply chains, and explore regional manufacturing partnerships. Manufacturers are optimizing logistics and reviewing pricing strategies to remain competitive while maintaining service levels. For clinical laboratories, these dynamics have accelerated consolidation of platforms, adoption of cost-efficient testing algorithms, and robust evaluations of testing utilization—all while maintaining analytical quality. These shifts require balancing operational efficiency and access to advanced diagnostics.

Colorectal Cancer Molecular Diagnostics Market: Methodology & Data Sources

Findings are derived from integration of peer-reviewed scientific literature, up-to-date regulatory guidance, clinical guidelines, technology validation studies, and corporate disclosures. Cross-validation with independent laboratory and clinical outcome reports ensures robust analytical rigor and relevance. Scenario analysis of policy and supply chain variables supports practical insight for stakeholders.

Why This Report Matters for Senior Leaders

  • Informs technology investment and partnership strategies through clear analysis of evolving platforms, product types, and operational impacts.
  • Provides segment-level granularity, supporting resource allocation and prioritization based on region, technology adoption, and emerging biomarkers.
  • Equips decision-makers with a grounded understanding of clinical adoption pathways, regulatory landscapes, and the implications of macroeconomic factors like tariffs.

Conclusion

Colorectal cancer molecular diagnostics continues to advance, shaped by integrated technologies, evolving guidelines, and supply chain realities. Organizations that align clinical, operational, and strategic agendas are well-positioned to realize the benefits of precision diagnostics in an increasingly complex market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Colorectal Cancer Molecular Diagnostics Market, by Technology
8.1. Fluorescence In Situ Hybridization
8.2. Microarray
8.3. Next Generation Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Quantitative PCR
9. Colorectal Cancer Molecular Diagnostics Market, by Product Type
9.1. Instruments
9.1.1. PCR Systems
9.1.2. Sequencers
9.2. Kits Reagents
9.3. Software Services
9.3.1. Bioinformatics Services
9.3.2. Data Analysis Software
10. Colorectal Cancer Molecular Diagnostics Market, by Application
10.1. Companion Diagnostics
10.2. Predictive Testing
10.3. Prognostic Testing
10.4. Residual Disease Monitoring
11. Colorectal Cancer Molecular Diagnostics Market, by Biomarker
11.1. BRAF
11.2. KRAS
11.3. Microsatellite Instability
11.4. NRAS
12. Colorectal Cancer Molecular Diagnostics Market, by Sample Type
12.1. Blood
12.1.1. Plasma
12.1.2. Serum
12.2. Stool
12.3. Tissue
13. Colorectal Cancer Molecular Diagnostics Market, by End User
13.1. Academic Research Institutes
13.2. Diagnostic Centers
13.3. Hospitals Clinics
13.4. Reference Laboratories
14. Colorectal Cancer Molecular Diagnostics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Colorectal Cancer Molecular Diagnostics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Colorectal Cancer Molecular Diagnostics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Colorectal Cancer Molecular Diagnostics Market
18. China Colorectal Cancer Molecular Diagnostics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Agilent Technologies, Inc.
19.6. Bio-Rad Laboratories, Inc.
19.7. Exact Sciences Corporation
19.8. F. Hoffmann-La Roche Ltd
19.9. Guardant Health, Inc.
19.10. Hologic, Inc.
19.11. Illumina, Inc.
19.12. Myriad Genetics, Inc.
19.13. Qiagen N.V.
19.14. Sysmex Corporation
19.15. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESIDUAL DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESIDUAL DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESIDUAL DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BRAF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BRAF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KRAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KRAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KRAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROSATELLITE INSTABILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROSATELLITE INSTABILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROSATELLITE INSTABILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NRAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NRAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NRAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 164. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 168. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 170. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 172. EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 188. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 189. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 191. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 194. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 196. AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 213. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 214. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 216. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 217. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 219. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 220. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 221. ASEAN COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 225. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 226. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 228. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 229. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 231. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 232. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 233. GCC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 249. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 250. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 252. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 253. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 255. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 256. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 257. BRICS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 261. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 262. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 264. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 265. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2032 (USD MILLION)
TABLE 267. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 268. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 269. G7 COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. NATO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. NATO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. NATO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 273. NATO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 274. NATO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. NATO COLORECTAL

Companies Mentioned

The key companies profiled in this Colorectal Cancer Molecular Diagnostics market report include:
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Qiagen N.V.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.94 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Colorectal Cancer Test Kit Market - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Test Kit Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Molecular Oncology Diagnostics Market - Global Forecast 2026-2032 - Product Image

Molecular Oncology Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Market Report 2025 - Product Image

Colorectal Cancer Molecular Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034 - Product Image

Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034

  • Report
  • 359 Pages
  • Global
From
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030 - Product Image

Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030

  • Report
  • 540 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.